Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
ISPR
NASDAQ·Consumer Defensive·Tobacco·Mkt cap $65.4M
$1.23
▲ +7.89%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$1.07 - $3.87
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Down 59.7% over the trailing year
Total returns
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
Bear Case
1 risk
Growth
Moderate growth ahead
Global shift from traditional tobacco to alternative nicotine products
Value
Deep value opportunity - significant discount to Tobacco peers
Momentum
Falling
-33.3% over 3m
Quality
Thin
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 8, 2026
MAY 7, 2026
Reported EPS of -$0.17 vs -$0.02 consensus (-750.0% surprise). Revenue of $18.7M vs $22.6M expected (-17.3%).
EPS surprise · last 4Q
0 of 1 beats
Q2 26
-750.0%
Next: May 8, 2026
Revenue trend · last 8Q
—
—
—
+0%
-13%
-46%
-23%
-51%
Q3 24
Q4 24
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
$30.0M
$37.3M
$39.3M
$41.8M
$26.2M
$20.1M
$30.4M
$20.3M
Margins · last 8Q
Gross
17.0%
Operating
-33.9%
Profit
-32.5%
Wall Street consensus
Live ratings and price targets aggregated across covering analysts.
No analyst coverage on file for this stock yet.